G1 THERAPEUTICS - Stock Price History | GTHX
Historical daily share price chart and data for G1 THERAPEUTICS since 2021 adjusted for splits. The latest closing stock price for G1 THERAPEUTICS as of September 27, 2021 is 15.94.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high G1 THERAPEUTICS stock closing price was 67.97 on September 13, 2018.
- The G1 THERAPEUTICS 52-week high stock price is 37.07, which is 132.6% above the current share price.
- The G1 THERAPEUTICS 52-week low stock price is 10.81, which is 32.2% below the current share price.
- The average G1 THERAPEUTICS stock price for the last 52 weeks is 19.14.
|G1 THERAPEUTICS Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel, small-molecule therapies which address significant unmet needs in the treatment of cancer. The company's product pipeline consists of CDK4/6, Trilaciclib (G1T28), G1T38 and G1T48. G1 Therapeutics, Inc. is based in Research Triangle Park, NC.